Alerts will be sent to your verified email
Verify Email
VIMTALABS
|
Vimta Labs
|
Krsnaa Diagnostics
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.67 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
12.51 % | 8.55 % | 20.41 % |
|
5yr average Equity Multiplier
|
1.33 | 1.35 | 1.35 |
|
5yr Average Asset Turnover Ratio
|
0.82 | 0.54 | 0.84 |
|
5yr Avg Net Profit Margin
|
11.37 % | 11.94 % | 18.13 % |
|
Price to Book
|
9.22 | 3.12 | 11.7 |
|
P/E
|
49.49 | 34.35 | 60.11 |
|
5yr Avg Cash Conversion Cycle
|
122.88 Days | -61.33 Days | -55.2 Days |
|
Inventory Days
|
26.64 Days | 13.68 Days | 19.62 Days |
|
Days Receivable
|
95.75 Days | 115.54 Days | 30.92 Days |
|
Days Payable
|
309.83 Days | 297.83 Days | 64.69 Days |
|
5yr Average Interest Coverage Ratio
|
21.55 | 6.88 | 65.11 |
|
5yr Avg ROCE
|
16.46 % | 11.9 % | 26.01 % |
|
5yr Avg Operating Profit Margin
|
25.53 % | 25.94 % | 30.0 % |
|
5 yr average Debt to Equity
|
0.11 | 0.13 | 0.01 |
|
5yr CAGR Net Profit
|
43.08 % | 2.56 % | -4.08 % |
|
5yr Average Return on Assets
|
9.62 % | 6.39 % | 14.94 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
36.67 % | 27.11 % | 71.06 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 100.0 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.79 % | -0.27 % | -0.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.48 % | -0.83 % | 7.94 % |
|
Vimta Labs
|
Krsnaa Diagnostics
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|